Signal
Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device
- Category
- · Funding · Global
- Date
- September 23, 2026
- Source
- MedCity News
Summary
The Series A round was led by .406 Ventures, with support from Emerson Collective (managed by Yosemite), Forerunner, Serena Ventures and Japan-based MPower Partners. The post Teal Health Secures $22M for At-Home HPV Cervical Cancer Screening Device appeared first on MedCity News.
The company works in Oncology and Sexual & Reproductive, and this round at Series A ($22M) is new money into that part of the market. Compare it with other recent rounds to see whether prices here are rising or holding steady.
OVUM interpretation layer
The editorial read on this signal — pattern, market-structure implications, and what to watch next.
Sources
- MedCity News Primary source
The OVUM Intelligence Brief
Keep reading past this page
The week's funding, launches, and studies in women's health, in plain English.
Weekly. No spam. Unsubscribe anytime.